Introduction
The mental health of individuals is one of the critical concerns for modern healthcare. The high stress levels, the speed of processes within societies, and the significant expectations placed on individuals put much pressure on them. As a result, the mental health of nations worsens, and it becomes one of the most critical challenges for global health. The problem is complicated by the fact that numerous health disparities are observed across regions. People in various parts of the world do not have equal access to diagnosis and treatment.
Moreover, in some countries, patients with mental health disorders might be discriminated against or suffer from stigma. For this reason, it is critical to understand the question better to design effective interventions to address it. For instance, mood disorders, specifically major depression, are one of the most common types of mental diseases. However, it is managed differently across regions, depending on local conditions. In South Africa, clients may face barriers related to socio-demographic characteristics.
Mood Disorders
Mood disorders are a significant burden for the modern healthcare sector. Millions of individuals worldwide suffer from them, while symptom severity and the need for interventions and treatment vary (Sekhon & Gupta, 2023). Mood is a pervasive feeling tone that is endured internally and affects behavior and interactions with others (Sekhon & Gupta, 2023). For this reason, preserving its normal state is critical for daily interactions and personal and professional growth.
However, under the impact of various stressors, individuals can acquire a mood disorder or disruptions in emotions (Sekhon & Gupta, 2023). These include a set of conditions, such as hypomania, cyclothymia, mood dysregulation disorder, and major depressive disorder (Sekhon & Gupta, 2023). The last one is among the most well-known and common problems affecting people regardless of their social status, race, or gender (Sekhon & Gupta, 2023). That is why much attention is given to understanding the disease and its assessment.
Depression
The general definition of depression focuses on the changes in mood and well-being. Thus, it can be described as a mood disorder causing feelings of sadness, loss of interest, and undesired emotional states (Sekhon & Gupta, 2023). If the condition progresses, it affects all aspects of a person’s life, including relationships with others, work, behavior, decision-making, and everyday actions (Karrouri et al., 2021).
Furthermore, in severe cases, it might lead to a loss of the ability to control and enjoy life. Following the relevant statistics, depression is the second-leading cause of disability globally, and by 2030, it might become the leading factor (Karrouri et al., 2021). The risks of depression include the emergence of suicidal inclinations in patients and self-harm, or even death (Karrouri et al., 2021). For this reason, addressing depression is one of the central tasks of the modern healthcare sector.
Symptoms
In most cases, the disease can be diagnosed by paying attention to specific symptoms. Specialists distinguish between the primary and secondary criteria to be considered. The first group includes depressed mood and loss of interest or pleasure in activities for at least two weeks (Rose et al., 2020).
The second cohort comprises loss or gain of weight, feelings of guilt, difficulties in concentrating on a specific task, recurrent thoughts of death or suicide, fatigue, feelings of loneliness, and worthlessness (Rose et al., 2020). Changes in mood, anhedonia, and weight changes are the most common symptoms traditionally found in adults (Rose et al., 2020). For this reason, by addressing these symptoms and acknowledging their presence, a specialist might determine the condition and start treatment.
Causes
Despite numerous research studies, the disease’s etiology remains unclear. There is a tendency to differentiate genetic, hormonal, psychological, biological, and neuroimmunological factors (Sekhon & Gupta, 2023). Certain studies evidence the presence of genes that might cause depressive disorders (Sekhon & Gupta, 2023).
Therefore, they can be inherited, increasing the likelihood of acquiring the condition (Sekhon & Gupta, 2023). Medical conditions such as brain tumors, influenza, cancer, AIDS, and syphilis might also lead to the emergence and development of depression (Remes et al., 2021). Individuals who have issues with endocrine systems might also suffer from this mood disorder (Sekhon & Gupta, 2023).
Furthermore, stressful life changes, traumatic events, and difficulties at work and in other spheres of life might lead to the development of the disease (Remes et al., 2021). As for the neuroimmunological factors, inflammatory processes and specific subcortical reactions can also lead to depression in individuals (Remes et al., 2021). In such a way, a set of diverse causes might be responsible for the condition.
Treatment
The choice of therapy and treatment method depends on the person, the stage of the disease, and the desired outcomes. In general, there is a need to manage the acute phase of depression to ensure a patient can continue living in the usual ways (Karrouri et al., 2021). However, it should be followed by prolonged therapy to ensure that no relapses will emerge. Pharmacotherapy is an effective way to help patients in the acute phase.
In many cases, selective serotonin inhibitors (SSRIs) are prescribed to patients (Karrouri et al., 2021). Nowadays, they are the standard treatment for depression as it is critical to attain changes in mood and positive responses. In general, antidepressants are prescribed based on the severity of the condition and a patient’s response to it. Regarding outcomes, treating the acute phase can take several weeks and may be followed by additional treatments, such as psychotherapy.
Cognitive behavioral therapy (CBT) is another possible intervention for treating depression. Recent research evidences the effectiveness of CBT in managing the condition and promoting improvements (Gautam et al., 2020). The method involves altering patients’ thinking patterns and attitudes toward certain events to ensure they exhibit behaviors more appropriate for a happy life (Gautam et al., 2020).
In many cases, CBT is recommended as an adjunct to pharmacotherapy to prevent further deterioration (Gautam et al., 2020). The number of sessions depends on the patient’s responsiveness and the severity of the condition (Gautam et al., 2020). However, it is possible to expect significant improvements in clients’ lives, moods, and the ability to process complex states and respond to them. For this reason, CBT is one of the effective methods to struggle against depression.
Depression in South Africa
The information presented above evidences the prevalence of depression and the complexity of the challenge. Thus, statistics show that in middle-income countries such as South Africa, risks are higher and populations are disproportionately affected (Craig et al., 2022). Currently, around 9.8% of the adult population experiences major depression, and only 25% of them ask for treatment within 12 months (Cuadros et al., 2019). Additionally, the recent surveys conducted using the Patient Health Questionnaire indicate that around 23.6% of respondents have probable depression or anxiety (Craig et al., 2022).
Overall, the scores of depression prevalence range from 14.7% to 38.8% (Craig et al., 2022). The rates are highest for retired individuals aged 65 or older, divorced or widowed, lonely or separated, living in metropolitan areas, or with only a primary school education (Craig et al., 2022). It means that socio-demographic determinants of health are a critical factor influencing depression and its rates in South Africa.
Depression Perception
The investigation of the topic shows that the perception of depression might vary depending on the region and health literacy levels. In South Africa, citizens recognize this mood disorder as a severe mental health issue. Representatives of the country’s rural districts associate the condition with sleep deprivation, loneliness, mood changes, reduced concentration, and deep sadness (Masemola et al., 2022).
In this way, various population groups have a good overall understanding of the question and view it as serious, requiring specific interventions (Masemola et al., 2022). However, there is also a lack of awareness about the biological determinants of depression (Masemola et al., 2022). Furthermore, there is a serious problem: around 68% of individuals in South Africa may not be aware of services that could help them (Masemola et al., 2022). It means that although depression is recognized as a complex phenomenon, it is critical to enhance its perception among individuals.
Challenges
The information above shows that there are some specific challenges people with depression might face in South Africa. First, limited knowledge of available treatment options prevents them from seeking specialist care and improving the quality of their lives (Masemola et al., 2022). Moreover, barriers to help-seeking behaviors include social stigma, fear of judgment, existing gender norms and stereotypes, and a lack of societal support (Masemola et al., 2022). The research reveals that family, public mental health services, low income, and the environment are critical barriers to acquiring the care required to improve mental health status (de Wet & Pretorius, 2022). As a result, the problem remains significant; numerous people from diverse population groups suffer from mood disorders and have the fear of asking for help.
Stigma
The existence of certain social stigmas complicates the process of managing mental health issues in South Africa. It limits the uptake of mental health services and the integration of clients with this condition into the communities and society (Monnapula-Mazabane & Petersen, 2022). In many cases, individuals who have depression are not understood or excluded from daily interactions (Monnapula-Mazabane & Petersen, 2022).
As a result, there is a fear of expressing real feelings or asking for assistance. There is also an idea that diseases such as depression can be considered a sign of weakness and issues with masculinity (Monnapula-Mazabane & Petersen, 2022). For this reason, for men living in South Africa, depression becomes more complex because of the impossibility of admitting the mood disorder, finding a specialist, and acquiring the necessary treatment. The high levels of stigmatization are one of the core factors for addressing depression in the country.
Treatment
The approach to managing depression in South Africa is organized following standardized guidelines. A combination of pharmacological approaches and psychological interventions is selected as the option. However, there is a particular issue with the mental healthcare system’s resourcing and structure (Sorsdahl et al., 2023). This means that the provision of medication for patients with severe mental health conditions, including depression, might be complex (Sorsdahl et al., 2023).
There is a lack of antidepressants that can be distributed among the poor population groups (Sorsdahl et al., 2023). Additionally, the fear of substance abuse because of the high prevalence of this problem influences the distribution of required drugs and their availability to specific population groups (Bouwer et al., 2021). For this reason, although the healthcare sector recognizes the need for medications and specific treatments, there are still some issues with their accessibility that should be addressed.
Conclusion
Altogether, depression is one of the severe mood disorders. It critically influences people’s quality of life and might lead to suicidal behaviors. The symptoms also include loss or gain of weight, depressive thoughts, and inability to enjoy life. In South Africa, depression is also prevalent.
However, in some cases, clients with the condition might face barriers and stigma. That is why many patients prefer to avoid asking for help. The challenges might include stigma, gender stereotypes, issues, and a lack of understanding. It is critical to cultivate awareness of depression to improve the situation and help clients with it. Otherwise, the situation will worsen significantly, and more spending and effort will be required to face the challenge.
References
Bouwer, J. C., Govender, S., & Robertson, L. J. (2021). Medicines used in mental, neurological and substance use disorders in Gauteng, South Africa: A secondary analysis of the 2017-2018 provincial pharmaceutical database, Part 1. The South African Journal of Psychiatry, 27.
Craig, A., Rochat, T., Naicker, S. N., Mapanga, W., Mtintsilana, A., Dlamini, S. N., Ware, L. J., Du Toit, J., Draper, C. E., Richter, L., & Norris, S. A. (2022). The prevalence of probable depression and probable anxiety, and associations with adverse childhood experiences and socio-demographics: A national survey in South Africa. Frontiers in Public Health, 10.
Cuadros, D. F., Tomita, A., Vandormael, A., Slotow, R., Burns, J. K., & Tanser, F. (2019). Spatial structure of depression in South Africa: A longitudinal panel survey of a nationally representative sample of households. Scientific Reports, 9(1), 979.
de Wet, A., & Pretorius, C. (2022). From darkness to light: Barriers and facilitators to mental health recovery in the South African context. International Journal of Social Psychiatry, 68(1), 82-89.
Gautam, M., Tripathi, A., Deshmukh, D., & Gaur, M. (2020). Cognitive behavioral therapy for depression. Indian Journal of Psychiatry, 62(2), 223–229.
Karrouri, R., Hammani, Z., Benjelloun, R., & Otheman, Y. (2021). Major depressive disorder: Validated treatments and future challenges. World Journal of Clinical Cases, 9(31), 9350–9367.
Masemola, H. C., Moodley, S. V., & Shirinde, J. (2022). Perceptions and attitudes of black men in a rural district of South Africa towards depression and its treatment. South African Family Practice, 64(1), e1–e9.
Monnapula-Mazabane, P., & Petersen, I. (2022). Feasibility and acceptability of a mental health stigma intervention for low-income South African caregivers: A qualitative investigation. The South African Journal of Psychiatry, 28.
Remes, O., Mendes, J. F., & Templeton, P. (2021). Biological, psychological, and social determinants of depression: A review of recent literature. Brain Sciences, 11(12).
Rose, A. L., Hopko, D. R., Lejuez, C. W., & Magidson, J. F. (2020). Major depressive disorder. In P. Sturmey (Ed.), Functional analysis in clinical treatment (2nd ed., pp. 339–373). Elsevier Academic Press.
Sekhon, S., & Gupta, V. (2023). Mood disorder. StatPearls.
Sorsdahl, K., Petersen, I., Myers, B., Zingela, Z., Lund, C., & van der Weshuizen, C. (2023). A reflection of the current status of the mental healthcare system in South Africa. Mental Health, 4.